ural arteriovenous fistulas (DAVFs) are abnormal communications between dural arteries and dural venous sinuses, meningeal veins, or cortical veins. 20 They account for 10%-15% of intracranial arteriovenous malformations and are classified according to the location of the involved sinus, that is, transverse, sigmoid, or cavernous sinus DAVFs.
Dural arteriovenous malformations in the region of the hypoglossal canal (HCDAVFs) represent a rare subtype of DAVFs involving the anterior condylar confluence (ACC) and/or the anterior condylar vein (ACV). Their incidence in the literature could be underestimated, as they are often misclassified into other subtypes of DAVFs or referred to as DAVFs of the inferior petrosal sinus (IPS), jugular bulb, marginal sinus, skull base, or foramen magnum, which may further hinder their detection. 13, 17, 31, 47, 52, 55, 71 In recent small single-center series, HCDAVFs represented 3.6%-4.2% of all intracranial DAVFs; 13,45 otherwise, they have mainly been reported as case reports or smaller case series. The location around the ACC or ACV predisposes HCDAVFs to complex venous connections with the orbit, the posterior fossa dural venous sinuses, and the external and internal vertebral venous system. This rich potential for venous connections translates into a polymorphic clinical presentation that may mimic fistulas in other locations such as cavernous sinus DAVFs. 12, 17, 64 Moreover, the complex drainage patterns and connections may prove challenging for treatment strategies, in particular for transvenous embolization (TVE).
The advent of high-resolution 3D angiographic imaging techniques allows for the precise anatomical depiction of the fistulous point around the hypoglossal canal, providing invaluable information regarding drainage routes and therapeutic planning.
The goal of the present study was to perform a systematic literature review of all previously published cases of HCDAVF supplemented by HCDAVF cases from our own institutions. To facilitate understanding of HCDAVFs, a summary of the complex venous anatomy at the skull base is provided. Hypoglossal canal DAVFs are analyzed with regard to clinical presentation, imaging findings, variable venous drainage patterns, treatment strategies, outcome, and complications. Finally, we advance recommendations on how to diagnose and manage these rare types of intracranial DAVFs.
anatomy of the aCC and aCv
The ACC is a constantly observed small venous structure (5 mm in maximal diameter) of the skull base that was largely ignored even after Trolard described it in 1868, 72 until its recent rediscovery. 64 The ACC is located at the extracranial aperture of the hypoglossal canal at the skull base and, because of its connection to a rich venous network, represents a major venous crossroad. 64 The ACC, along with the other emissary veins of the skull base such as the posterior condylar vein (PCV) and the mastoid emissary vein (MEV), plays an important role in directing encephalic venous blood to the internal and external vertebral venous plexus (VVP). Indeed, while the internal jugular vein (IJV) represents the major cerebral venous outflow pathway in the supine position, the bulk of venous drainage through the posterior fossa dural venous sinuses is redirected to the vertebral venous system in an upright position. 16, 64, 76 The ACC has direct connections with the IJV, IPS, ACV, internal carotid artery of the venous plexus (ICAVP; by way of the inferior petrooccipital vein), and lateral condylar vein (LCV), 64, 72 all of which are venous channels devoid of valves, allowing for multidirectional venous flow (Fig. 1) . Of clinical importance is the indirect connection of the ACC to the cavernous sinus by way of the IPS and ICAVP (see Results, Venous Drainage Pathways) . 64 Connections to the vertebral venous system occur mainly through the ACV and LCV. The ACV is the cranial extension of the anterior internal VVP (AIVVP) and runs in the hypoglossal canal, along the hypoglossal branch of the neuromeningeal division of the ascending pharyngeal artery, and forms a plexus around the hypoglossal nerve. Furthermore, the ACV may connect intracranially and extradurally with the basilar plexus. The latter structure allows for indirect connections with the posterior compartment of the cavernous sinus and with the anterior pial brainstem veins via the emissary bridging veins. 42, 61, 69 The LCV generally arises from a bridging vein between the ACC and the IJV and connects to the anterior portion of the vertebral artery venous plexus (VAVP) at the level of C-2. It runs laterally to the occipital condyle and may be contained in an osseous canal.
72
It is thus related to the external vertebral venous system, which may become a major drainage pathway in cases of HCDAVF.
Indirect connections of the ACC and ACV with the IJV and dural venous sinuses of the posterior fossa occur in the following manner: First, the ACC is connected to the superior portion of the IJV or the IJV bulb by one or more bridging veins, allowing for retrograde venous flow into the sigmoid and transverse sinuses in cases of HCDAVF. Second, the ACV is connected to the marginal sinus, with the latter located in the dural layers at the margin of the foramen magnum. 74 In the literature, there is some confusion over the anatomy of the marginal sinus, some authors considering it equivalent to the terminal (distal) portion of a persistent occipital sinus connecting the torcular herophili with the IJV bulb or sigmoid sinus and/or IJV bulb junction. 19 San Millán Ruíz et al. 64 found, based on a corrosion cast study of the cranial venous system, that the marginal sinus is invariably connected to the ACV anteriorly. Posteriorly, the marginal sinus may connect with the veins of the suboccipital region or at times represent the major drainage pathway of a persistent occipital sinus (unpublished data, 2014) .
Methods

Systematic literature review
We aimed to identify in the medical literature all cases of HCDAVF that were described with detailed clinical and angiographic information. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 53 guidelines were followed as far as applicable. The senior author (9 years of neuroangiographic experience) and a biomedical librarian (30 years of experience) reviewed the literature as follows: First, three medical databases (PubMed, Embase, and Web of Science) were systematically reviewed for HCDAVFs, including the various other subtypes of DAVFs that HCDAVFs have been referred to in the past, by applying a dedicated search strategy (Appendix Tables 1-3) abstracts were prescreened according to clinical descriptions, angiographic findings, and treatment details. Only articles published in the English language were considered. Suitable articles were carefully scrutinized in full text to determine whether they fulfilled the following criteria: comprehensive angiographic and/or cross-sectional imaging findings of DAVF (including arterial feeders, venous drainage, location of fistulous point), clinical presentation and follow-up, and description of treatment (conservative, endovascular, or surgical, including all available details and outcome). Of these articles, those describing suitable subtypes of DAVFs (for example, marginal sinus DAVF) were checked to determine whether the angiographic and anatomical descriptions matched the characteristics and location of an HCDAVF. In many of these reports, the angiographic descriptions and images showed striking similarities to an HCDAVF with respect to fistula points (for example, inferior end of the IPS, medial to jugular bulb for so-called IPS DAVFs), arterial feeders, and venous drainage patterns (antegrade to the IJV and/or VVP, retrograde into the cavernous sinus and the superior ophthalmic vein (SOV), or direct perimedullary drainage via emissary bridging veins). 1, 3, 5, 6, 10, 31, 34, 38, 41, 42, 50, 58, 62, 71, 81 Second, the latter articles were screened for related articles and references, which were then assessed according to the same aforementioned criteria.
Angiographic Classification of HCDAVF
McDougall et al. classified venous drainage in HCDAVFs into 3 categories: Grade 1, unrestricted drainage to the region of the ipsilateral jugular bulb; Grade 2, absent or restricted drainage to the ipsilateral jugular bulb; and Grade 3, retrograde cortical venous drainage. 47 Based on the assessment of HCDAVFs in the present review, we propose a modified classification of the predominant venous drainage pattern into 3 categories relative to the distinct clinical presentation patterns: Type 1, dominant anterograde venous drainage to the IJV and/or the VVP with or without reflux to the transverse, sigmoid, inferior petrosal, or cavernous sinus; Type 2, dominant retrograde drainage to the cavernous sinus and/or orbital veins with or without anterograde drainage to the IJV and/or VVP or cortical venous reflux; and Type 3, dominant or exclusive venous drainage to cerebellar pial or perimedullary veins (Fig. 2) . All HCDAVFs were grouped into these 3 types of venous drainage based on available images and/or angiographic descriptions by the senior author.
Statistical analysis
The significance of differences in frequency of clinical presentation patterns across the three groups of venous drainage was assessed using stratified exact logistic regression, with single publications as strata (Stata version 12.1, StataCorp LP). All papers contributing only one case were combined in one stratum. Only if the overall comparison of all groups was significant were pairwise comparisons performed. For all group comparisons, p values ≤ 0.05 were considered as statistically significant. Likewise, differences were also analyzed for the therapeutic outcome (angiographic occlusion, clinical cure, and permanent morbidity) across the 4 major treatment modalities (endovascular treatment [EVT] , surgery, radiotherapy, and conservative) and the 3 EVT subgroups (TVE including combined transarterial embolization [TAE] and TVE procedures, TAE using liquid embolic agents, and TAE procedures with other agents). Cases in which clinical and/or angiographic outcomes were not reported were excluded from the respective analysis of outcome.
results literature review results
Results of the literature review process are illustrated in Appendix Fig. 1 . One hundred thirteen cases of HCDAVF in the literature have been described mainly in case reports (21 articles), smaller case series (16 articles) with the largest series comprising 14 cases, 47 or as part of series comprising different types of DAVFs (11 articles). After further inclusion of 7 personal cases, a total of 120 HCDAVFs were identified. Table 1 summarizes the clinical presentation and venous drainage patterns of all HCDAVFs. The individual details from all reviewed cases are summarized in Appendix Table 4 .
Presentation and Clinical Findings
By and large, patients presented with pulse-synchronous tinnitus (PT; 75% of all fistulas), which could be explained by direct transmission of the venous bruit to the inner ear through the temporal bone. PT was often the only symptom in HCDAVFs with solely anterograde venous drainage (Type 1), 1, 45 or it was found in addition to other of the below-mentioned symptoms. PT showed a significant association with venous drainage Types 1 and 2 (Type 1 vs 3: p < 0.0001, Type 2 vs 3: p < 0.0001) and did not occur in venous drainage Type 3 HCDAVFs. Headache was another commonly encountered but nonspecific symptom.
Orbital symptoms (chemosis, proptosis, and/or diplopia from oculomotor or abducens nerve palsies) due to reflux into the cavernous sinus and SOV (by way of the IPS and ICAVP) were the second most frequent clinical presentations (30.8% of HCDAVFs). 2, 10, 12, 13, 23, 31, 36, 51, 69, 75, 81, 82 They reached a prevalence of 100% in the venous drainage Type 2 (Fig. 3) and were rather infrequent in the other venous drainage types (p < 0.0001 for Type 1 vs 2 and Type 3 vs 2). In these instances, symptoms were indistinguishable from those of cavernous sinus fistulas. Mironov et al. reported the case of an HCDAVF that caused ipsilateral tinnitus and contralateral orbital symptoms due to retrograde drainage into the contralateral cavernous sinus and/ or SOV via the intercavernous sinus.
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Hypoglossal canal DAVFs may occasionally present with hypoglossal nerve palsy or involuntary tongue movements (11.7% of HCDAVFs) related to pulsatile compression and venous hypertension from a dilated ACV within the hypoglossal canal. 6, 13, 39, 52, 71 Hypoglossal nerve palsy was present only in venous drainage Type 1 HCDAVFs, and its prevalence there (18.7%) was significantly higher than in venous drainage Type 2 HCDAVFs (p = 0.0089). In 50% (7 of 14) of these fistulas, retrograde venous drain-age to the ipsilateral IPS was present; one of them showed additional venous reflux to the transverse, sigmoid, and bilateral cavernous sinuses. No orbital or cortical venous reflux was identified in these fistulas.
Intracranial hemorrhage was encountered in only 6 cases (5% of HCDAVFs), 4 presenting with posterior fossa subarachnoid hemorrhage and 1 with cerebellar intraparenchymal hemorrhage. In these cases, venous drainage occurred exclusively toward the pial posterior fossa veins 24, 28, 47, 62 and/or into the perimedullary and/or peri- spinal veins. 9, 24, 28, 62 Hence, the prevalence of hemorrhage was significantly more frequent in HCDAVFs with venous drainage Type 3 versus Types 1 and 2 (p = 0.0013 and 0.0195, respectively). Venous drainage Type 3 HCDAVFs may also produce symptoms related to cervical myelopathy due to perimedullary venous hypertension (10.8% of HCDAVFs). 3, 11, 13, 18, 25, 26, 46, 47, 69, 79 The prevalence of myelopathy in Type 3 HCDAVFs was significantly more common than in Types 1 and 2 (p = 0.0046 and 0.0004, respectively).
Other rare clinical symptoms included dizziness, otalgia and/or ear fullness, and facial nerve palsy (4.2% of HCDAVFs). 12, 13, 27 As in DAVFs in other locations, symptoms may change occasionally in relation to spontaneous occlusion of one draining pathway, after partial fistula occlusion, or because of high-flow vasculopathy with draining vein stenosis. In such instances, the redirection of flow to another draining route may result in the disappearance of PT or the subsequent development of ocular symptoms, hypoglossal nerve palsy, or even congestive myelopathy. 13, 17, 39, 52, 73 Rarely, Type 1 HCDAVFs may be asymptomatic.
imaging Findings and angiographic anatomy
Distinguishing HCDAVF from other skull base DAVFs, such as posterior condylar canal or inferior petroclival vein fistulas, 30,66 may be challenging and implies a thorough knowledge of the complex venous anatomy. The radiological hallmark of HCDAVF is the presence of an arterialized ACC and/or ACV representing the fistulous point. However, HCDAVFs may be difficult to visualize radiologically. Indeed, several previously reported DAVFs, which could very likely be classified as HCDAVF, were often described on conventional digital subtraction angiography (DSA) as being located at the skull base, foramen magnum, craniocervical junction, jugular foramen, jugular bulb, IPS, or marginal sinus. 5, 6, 9, 11, 12, 23, 24, 26, 28, 37, 42, 44, 46, 47, 50, 60, 62, 71, 73, 78, 81, 82 Cross-sectional imaging techniques aim at demonstrating an arterialized ACC and/or ACV, a venous pouch corresponding to a dilated ACC and/or ACV, dilated and tortuous pial or perimedullary veins, and intraosseous fistula components. The latter may exist within the lower clivus and/or occipital condyle around the hypoglossal canal, on the medial wall of the jugular bulb, within the jugular process, within jugular tubercle of the occipital bone, and around the opening of the posterior condylar canal. 29, 42, 71 Arterialized veins may be demonstrated on CT angiography (CTA) 48 if the image is obtained during the early arterial phase, and CTA may show conspicuous filling of the HCDAVF. Subtracted dynamic whole-head CTA using a multi-row (320) detector scanner overcomes limitations due to partial volume with bone and provides hemodynamic information similar to DSA (Videos 1 and 2). Standard MRI is not sensitive in detecting DAVFs and may fail to demonstrate an HCDAVF entirely (Fig.  4) . Rarely, an HCDAVF can mimic a hypervascular skull base tumor on standard MRI. 39 Source images of timeof-flight (TOF) magnetic resonance angiography (MRA) generally detect the arterialized ACC and/or ACV as well as the precise anatomical localization of the venous pouch. 1, 13, 15, 17, 27, 31, 45, 69 However, low-grade HCDAVFs can remain undetected, and false-positive results can occur because of retrograde flow-related signal in the skull base veins, in particular, in the IPS.
56 Dynamic 4D MRA techniques may represent, as with lesions in other locations, a valuable additional tool, as they provide information similar to DSA, although the lower spatial and temporal resolutions may fail to demonstrate the exact angiographic characterization of HCDAVFs, in particular, in low-grade fistulas. 49, 54 In some cases, expansion of the hypoglossal canal may be observed as a valuable indirect sign on CT.
13,45 The intraosseous fistula components, which correspond to dilated diploic veins, may be well demonstrated on MRI, particularly with postcontrast 3D T1-weighted MRI and 3D TOF MRA. 10, 17, 27 100 (120) 75% (90) 30.8% (37) 11.7% (14) 10.8% (13) 5% (6) † Significant differences in clinical presentation for pairwise group comparisons between venous drainage Types 1 versus 3. * Significant differences in clinical presentation for pairwise group comparisons between venous drainage Types 1 versus 2. ‡ Significant differences in clinical presentation for pairwise group comparisons between venous drainage Types 2 versus 3. § Refers to a global test of group differences in clinical presentation between all three types of venous drainage.
Conventional DSA, especially if coupled with 3D rotational angiography and C-arm cone-beam CT imaging, remains the gold standard for depicting the fistulous location, the arterial supply, and the venous drainage routes of an HCDAVF. Furthermore, DSA allows for the assessment of arterial and venous access to the fistulous point. All of these factors are indispensable for planning treatment. In particular, source images from 3D DSA techniques allow for the precise localization of fistulous points and drainage pathways including draining vein stenosis in relation to bony structures of the skull base. 13, 27, 36, 52 The arterial supply of an HCDAVF derives in particular from the neuromeningeal division of the ascending pharyngeal artery (92% of HCDAVFs) and the transmastoid branches of the occipital artery (56.3%) supplemented by meningeal VA branches of the V3 and V4 segments (47.3%) and clival branches of the meningohypophyseal trunk (21.4%), which oftentimes may be bilateral. 47 Less frequently, branches from the posterior auricular (13.4%), middle meningeal (14.3%), accessory meningeal, and internal maxillary (5.4%) arteries may contribute. Angiographically, this rich network of arterial supply may produce the erroneous impression of a wide area of fistulous involvement rather than a focal location at the ACC or ACV. In this respect, contralateral carotid artery injections as well as supraselective microcatheter injections may be particularly useful to precisely delineate the fistulous point without overlapping crowded vasculature. 13, 17, 31 venous Drainage Pathways
Owing to the rich network of connections of the ACC and ACV, HCDAVFs may display complex venous drainage patterns. 12, 13, 45, 64 In most fistulas (62.5%), venous drainage Type 1 to the jugular bulb and IJV and/or the VVP was observed. In contrast, 23.3% of HCDAVFs showed retrograde orbital venous drainage (Type 2; Fig. 3 ) correlating with orbital symptoms (see Presentation and Clinical Findings) . Some fistulas with reflux only to the IPS 
(arrowheads) into the SOV (thin arrow). Digital subtraction angiograms (C-e) confirm a DAVF with a venous pouch within
the hypoglossal canal (arrows in C and D, right ECA injections) and also show angiographic architecture with feeders from the ipsilateral occipital, ascending pharyngeal (not shown), middle meningeal, and distal internal maxillary arteries, as well as numerous small branches of the VA (arrowheads in e, right VA injection). In addition, little supply originating from the contralateral ascending pharyngeal artery and VAs was seen (not shown). Note the anterograde venous drainage via several venous channels into the IJV (arrowheads in C). A guide catheter was placed in the upper IJV, while microwire enters the venous channel to the fistula pouch. On a later-phase image, fistula reflux into the IPS is seen, with the cavernous sinus (arrowheads in D) reaching the SOV (thin arrow in D). In addition, the fistula drains anterogradely via the condylar veins to the vertebral and suboccipital venous plexus. A microcatheter system (Excelsior SL-10, Transend EX 14 [Boston Scientific]) was used to pass through the fistulous pouch and IPS to access the right cavernous sinus (arrow in F). Superselective injection shows fistula reflux to the SOV (arrowhead in F). A second microcatheter system (Excelsior 1018, Synchro 14 [Boston Scientific]) was then introduced into the fistula pouch for subsequent coil embolization using soft coils to minimize pressure on the hypoglossal nerve. Unsubtracted image during coiling demonstrates the first coil placed inside the venous pouch (arrow in g). During coiling, the first microcatheter was left in the cavernous sinus (arrowheads in G) as rescue access in case of a potential residual fistula or re-routed upstream flow. Final angiogram (H) obtained after coil occlusion of the hypoglossal pouch (arrow), showing complete DAVF occlusion. At this point, the first microcatheter was removed. On a follow-up visit 1 month later, symptoms had disappeared. Follow-up MRA after 5 months showed no residual DAVF. and the cavernous sinus did not necessarily present with orbital symptoms. Anatomical variation, very high flow HCDAVFs, outflow venous stenosis of the connections to the VVP or IJV, or thrombosis may result in dominant retrograde Type 2 drainage. 5, 13, 38, 50, 51, 75, 82 Rarely, contralateral cavernous sinus and/or SOV drainage via the intercavernous plexus 2,12,50 or drainage to the contralateral IJV via a prevertebral anastomosis in between both ACCs (Fig. 5 ) may be observed. Retrograde flow to the transverse and/ or sigmoid sinuses was observed in 8.3% of HCDAVFs, as well as into the superficial middle cerebral veins and superior petrosal sinuses by way of the cavernous sinus and IPS in 1.7% and in 0.8% of HCDAVFs, respectively. 31 Retrograde cortical venous drainage was observed in 13.3% of HCDAVFs, 2, 12, 17, 24, 27, 47, 51, 62 often seen in combination with retrograde orbital drainage (Type 2) and partially associated with orbital symptoms without intracranial hemorrhage. Exclusive cortical or perimedullary (Type 3) venous drainage was observed in 14.2% of HCDAVFs that presented with either intracranial hemorrhage 24, 28, 47, 62 or cervical myelopathy 3, 11, 18, 25, 26, 46, 47, 69, 79 (see Presentation and Clinical Findings) . These fistulas were located on the intracranial ACV portion and drained directly into the pontomesencephalic veins by way of the emissary bridging veins with subsequent ascending (toward the cerebellar pial or petrosal veins) or descending (to the anterior and/ or posterior spinal veins) perimedullary venous drainage. In these cases, no demonstrable anastomosis between the ACV and the IPS, IJV, or VVP was seen, probably because of the thrombosis.
69 By contrast, thrombosis may also develop within the perimedullary drainage route with subsequent cord infarction and rerouting of drainage toward the VVP or the IPS and cavernous sinus.
73 Choi et al. reported a case of HCDAVF with high-grade stenosis at the connection between the ACC and IJV, which resulted in perimedullary spinal drainage in the absence of other draining routes from the ACV. 13 In most Type 3 HCDAVFs presenting with myelopathy, MRI of the cervical spine revealed brainstem and upper spinal cord edema. Further, MRI may also show abnormal engorged perimedullary spinal veins with or without thrombosis, contrast enhancement of the spinal cord, or even medullary compression by focal venous ectasia. 3, 11, 13, 18, 25, 26, 46, 59, 69 TOF MRA (D) shows abnormal flow signal (arrow) within the left hypoglossal canal without intracranial or extracranial extension. Correspondingly, dynamic 4D contrast-enhanced MRA study (e) shows early enhancement of hypoglossal canal (medial to jugular bulb, arrow) during the arterial phase with faint opacification of the left IJV (arrowheads). Clinically, spontaneous, complete resolution of symptoms was observed 12 months after initial presentation. On a follow-up MRA study after 15 months (F), the absence of early venous filling at the hypoglossal canal because of fistula occlusion is visible.
therapeutic Management of HCDavFs
The therapeutic management, outcome, and morbidity of all HCDAVFs are summarized in Table 2 . The individual details from all reviewed cases are summarized in Appendix Table 5 . Treatment was performed in 92.5% of HCDAVFs. Treatment was rendered if a high-grade fistula with orbital, cortical, or perimedullary venous reflux was present 75 or in cases of intolerable PT. Moreover, 76.7% of HCDAVFs were treated with EVT, whereas the others were treated using surgery, including combinations with EVT and/or radiosurgery (12.5%) and radiotherapy or stereotactic radiosurgery with or without EVT (3.3%). Given the small size of the latter two groups and the comparable outcomes among the four major treatment groups (EVT, surgery, radiotherapy, and conservative), no significant differences between the four treatment modalities were demonstrated. Overall, EVT resulted in 93.4% angiographic fistula obliteration, 5.4% permanent morbidity, and 0% mortality. Among the patients with EVT, the majority was treated with TVE (56.7% of HCDAVFs), of which 75% involved TVE exclusively and 25% involved combined TAE and TVE procedures. Other EVT procedures included TAE with liquid embolic agents (15%), TAE with other agents (4.2%), and 1 case (0.8%) of nonspecified EVT. Again, among these EVT subgroups, no significant difference in outcomes was observed. In the EVT groups, angiographic occlusion rates varied between 80% and 94.4%, clinical cure rates between 58.8% and 91%, and permanent morbidity between 2.9% and 16.7%.
TVE led to the highest rate of clinical cure (91%) at a relatively low therapeutic risk (permanent morbidity 2.9%). The most direct route for TVE of an HCDAVF is trans-IJV access. In some cases, however, a transvenous approach via the ipsilateral IJV may be impossible because of occluded or extremely small and tortuous connecting veins to the venous pouch. In such cases, a crossover transvenous route through the contralateral IJV and IPS, intercavernous sinus, and ipsilateral cavernous sinus and IPS to the recipient fistulous pouch may be feasible. 12, 44, 47 Contralateral IJV access can also be achieved through prevertebral connections between both ACCs (Fig. 5) . Alternatively, TVE may also be possible via the VVP or the SOV following direct surgical access. 12, 23, 34, 36, 45, 51, 69 In the majority of TVEs, coils were used to obliterate the fistulous venous pouch at the ACC and/or the ACV (92.7%). Other embolic materials used in TVE were Onyx (2.9%), Onyx and coils (2.9%), and silk and coils (1.5%). In three reports, TVE of an HCDAVF was complicated by transient (2 cases) and permanent (1 case) hypoglossal nerve palsy after coil embolization of the fistulous pouch, 45,47,52 presumably due to mass effect from coils on the hypoglossal nerve. Some authors have recommended using soft rather than stiff coils and avoiding tight packing and/or overpacking with coils to reduce the risk of hypoglossal nerve palsy. 45, 52 In addition, precise localization of the shunting point by superselective 3D rotational DSA may enable placing the coils into the ACC rather than within the constrained hypoglossal canal. 45, 52 Three patients developed dural venous sinus thrombosis (1 asymptomatic; 2 with transient and permanent morbidity, respectively) following TVE procedures with coils and silk and with Onyx, presumably due to reflux of the embolic agents into the jugular bulb. 5 In TVE with coils, a double microcatheter technique, in which one microcatheter is placed distally into the cavernous sinus and/or the IPS and another one is placed proximally into the venous pouch, may be advantageous (Fig. 3) . The distal microcatheter may serve as a rescue access to the fistula in case the proximal microcatheter kicks back proximally or in case of residual fistula flow distally after coil occlusion proximally at the ACC. 67, 74 Recently, Takemoto et al. presented a series of 3 HCDAVFs that had been treated transvenously using Onyx combined with coils (2 lesions) or with Onyx only (1 lesion) injected into the recipient fistulous pouch.
68 These authors achieved complete fistula occlusion in all cases and observed a transient hypoglossal palsy in 1 case. This approach is potentially advantageous because overpacking with dense coils, leading to undesirable hypoglossal nerve palsy, may be avoided because of the nonadhesive and cohesive properties of Onyx, as in cavernous sinus fistulas.
67,68 However, potential complications include direct neurotoxicity of the dimethyl sulfoxide solvent (for example, trigeminocardiac reflex) and retrograde arterial embolization of Onyx into the vasa nervorum supplying a cranial nerve. 21, 40, 68 Transarterial embolization using polyvinyl alcohol (PVA) particles was generally not considered a primary treatment modality because of a higher tendency for fistula recurrence, although it may serve to reduce fistula flow. 13, 17, 36, 42, 45, 47, 81 Transarterial embolization using liquid embolic agents such as N-butyl cyanoacrylate (NBCA) or Onyx is indicated in cases of Type 3 HCDAVFs with exclusive cortical and/or perimedullary venous drainage or when transvenous access to the fistulous site is not possible. 9, 11, 18, 25, 47, 62, 69, 79 However, TAE with liquid embolic agents carries a significant risk of lower cranial nerve palsies, as HCDAVFs are commonly supplied by the neuromeningeal division of the ascending pharyngeal artery, which also supplies the vasa nervorum of cranial nerves IX, X, XI, and XII. 9, 22, 33, 45, 65 Moreover, the dangerous anastomosis between the ascending pharyngeal artery and the ICA and/or VA may represent the risk of stroke in TAE. Three cases (16.7%) of permanent morbidity with TAE using liquid embolic agents were identified: 2 hypoglossal nerve palsies following TAE with Onyx 58 (Fig. 6 ) and 1 brainstem infarct following an NBCA injection.
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In this review, only 4 HCDAVFs were treated using surgery alone (ligation of major arterial feeders or transection at the dural exit of the vein). 24, 42, 46, 50 Combined surgical obliteration following preoperative TAE was used to treat another 8 HCDAVFs, including 5 cases with intraosseous components described by Tirakotai et al. that underwent surgical treatment via a suboccipital transcondylar approach. 3, 41, 47, 71 One case of Type 1 HCDAVF, which was mistaken for a glomus tumor, was treated using combined surgery and embolization via a far-lateral transcondylar surgical approach. 39 Two recurrent intraosseous HCDAVFs were surgically treated after unsuccessful TAE and TAE plus stereotactic radiotherapy, respectively.
42 Surgical complications included occipital condyle fracture with craniocervical instability and hypoglossal nerve injury in 2 (13.3%) of 15 surgical cases. Earlier reports on skull base DAVFs, presumably in the location of the hypoglossal canal, have also demonstrated successful combined endovascular and surgical approaches. 41, 42 Despite an overall high efficacy of surgical or combined endovascular and surgical treatments for intracranial DAVFs, the risk of morbidity and mortality remains considerable (> 10%).
20 However, surgery may be indicated in cases of Type 3 HCDAVFs with eloquent or poorly accessible feeders. In such cases, the decision to treat with TAE versus surgical obliteration should be made on an individual basis after careful consideration of the clinical conditions, surgical accessibility, and angiographic feeding artery anatomy. Two HCDAVFs were treated with TAE using PVA followed by stereotactic radiosurgery, which resulted in only partial relief of symptoms. Complete fistula obliteration was only achieved after final TVE 17 and surgery. 37 In general, stereotactic radiosurgery as the sole treatment has demonstrated low obliteration rates for DAVFs. 20, 83 Moreover, the long latency period to achieve obliteration of the shunt in stereotactic radiosurgery is probably inappropriate for Type 3 HCDAVFs because of the high risk of nonhemorrhagic and/ or hemorrhagic complications intrinsic to such high-grade DAVFs. Therefore, stereotactic radiosurgery should be reserved for select fistulas for which endovascular and surgical approaches have been exhausted.
Spontaneous occlusion of an HCDAVF was observed in 5.8% of cases, including 4 of 9 cases in a series by Manabe et al. 6, 45 In all of these cases with mostly Type 1 HCDAVFs, neurological improvement after spontaneous thrombosis was observed even though some had presented with cranial nerve palsies (Fig. 4) . These cases support the benefits of a conservative strategy in low-grade HCDAVFs with subjectively tolerable symptoms (PT).
limitations of a literature review
Since HCDAVFs are so rare, available data can only be obtained from published case reports or small retrospective single-center series (see Literature Review Results). Therefore, the descriptive figures for these fistulas summarizing the angiographic and clinical findings, treatment modalities, and complications are probably subject to publication bias. As a consequence, rare findings, such as hypoglossal nerve palsy at presentation, or retrograde orbital venous flow may be overrepresented in this review. On the other hand, treatment of these fistulas may occur rather infrequently in large tertiary neurointerventional centers, which may provoke a tendency to include all available cases into published case series. Moreover, some reports or book chapters briefly mention DAVFs at the skull base and/or IPS possibly in the vicinity of the hypoglossal ca- Bone-window CT image (F) obtained after embolization, demonstrating Onyx cast inside the hypoglossal canal (arrow) and at the ACC. Residual fistula flow was seen from VA feeders (not shown). Clinically, the patient developed left hypoglossal and cranial nerve X palsies and was treated with steroid boost therapy. Near-complete recovery of tongue function with atrophy was observed after 11 months. PT was completely absent, and complete HCDAVF occlusion was seen on vascular ultrasonography.
nal, probably representing HCDAVFs, without specifying angiographic findings, therapy, and outcome, which we thus subsequently excluded from our series. 4, 63, 70 Other reports describe fistulas with exclusive cortical and/or perimedullary drainage located at the foramen magnum and/ or skull base without surgically or radiologically proven involvement of the ACC and/or ACV, which we also excluded from our analysis, 8, 35, 43, 60, 77 although they probably correspond to HCDAVFs. Finally, published cases of HC-DAVF may not have been detected in our literature search because they were categorized as DAVFs in another location and the publications did not provide illustrations of the cases.
Conclusions
Hypoglossal canal DAVFs are rare (approximately 3%-4% of cranial DAVFs) and consist of a fistulous pouch involving the ACC and/or ACV with a variable intraosseous component. Owing to the rich network of venous skull base anastomoses, HCDAVFs may display complex drainage patterns. Three major types of venous drainage are associated with distinct clinical patterns: Type 1, dominant anterograde drainage (62.5% of HCDAVFs), usually presents only with PT; Type 2, dominant retrograde orbital drainage (23.3% of HCDAVFs), associated with orbital symptoms (100%) and may clinically mimic cavernous sinus DAVF; and Type 3, exclusive pial and/or perimedullary drainage (14.2% of HCDAVFs), presents with intracranial hemorrhage or cervical myelopathy. Hypoglossal nerve palsy was a presenting finding in 11.7% of HCDAVFs. For Type 1 and 2 HCDAVFs, TVE may be an adequate treatment, demonstrating high safety (permanent morbidity 2.9%; mortality 0%) and efficacy (angiographic occlusion 92.7%). Understanding the complex venous anatomy is crucial for planning alternative TVE approaches if standard transjugular access is not possible. TAE and/or surgical fistula disconnection are alternative options for Type 3 HCDAVFs or if TVE is not possible. Finally, a conservative strategy may be followed in Type 1 HCDAVFs since numerous spontaneous occlusions have been described. 
Supplemental information
Previous Presentation
Parts of this work were presented at the cl = contralateral; CS = cavernous sinus; FND = focal neurological deficit; HEM = intracranial hemorrhage; HP = hypoglossal palsy; MP = myelopathy; OD = orbital venous drainage; OS = orbital symptoms; PM = perimedullary and perimesencephalic drainage; RC = retrograde cortical drainage; SphS = sphenoparietal sinus; SPS = superior petrosal sinus; SS = sigmoid sinus; TS = transverse sinus. * Series included various types of DAVFs and the indicated number corresponds to HCDAVFs.
aPPeNDiX Fig. 1 (1) HP (1), VT(1) CO(6), SpO(1) CR (7) CC = common carotid; cl = contralateral; CO = complete occlusion; CR = complete recovery; EVAL = ethylene vinyl alcohol copolymer; HP = hypoglossal palsy; il = ipsilateral; NA = not available; NS = not specified; others = hypertonic glucose, PVA, and Gelfoam; PO = partial occlusion; PR = partial recovery; RT = radiotherapy; SpO = spontaneous occlusion; StereoS = stereotactic surgery; VT = venous sinus thrombosis. † Only one asymptomatic fistula with antegrade drainage was not treated. * Series included various types of DAVFs and only the indicated number corresponds to HCDAVFs. ‡ Death was related to cerebellar hemorrhage after the patient had been lost to follow-up for 1 year following incomplete endovascular HCDAVF occlusion.
